<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2010-09-14" updated="2019-12-02">
  <drugbank-id primary="true">DB06776</drugbank-id>
  <name>Sodium cellulose phosphate</name>
  <description>Sodium cellulose phosphate is used to treat hypercalcemia and hypercalciuria. It has been used to prevent kidney stones. [A31694]&#13;
&#13;
This compound is an ion-exchange resin that can not be absorbed by the body. However, it can be used to restore normal intestinal calcium absorption.</description>
  <cas-number>9038-41-9</cas-number>
  <unii>E6S1NJ4Y5Q</unii>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A31694</ref-id>
        <pubmed-id>3896714</pubmed-id>
        <citation>Lake KD, Brown DC: New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate. Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):530-9.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L1190</ref-id>
        <title>WikiDoc: Editor-In-Chief: C. Michael Gibson, M.S., M.D. </title>
        <url>https://www.wikidoc.org/index.php/Sodium_cellulose_phosphate</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action>When it is taken orally, it stays in the intestine and it binds strongly to calcium inhibiting its intestinal absorption. From there, inhibition is caused due to the lower intraluminal calcium levels, which is typically available for absorption.[L1190]</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Cellulose dihydrogen phosphate, disodium salt</synonym>
    <synonym language="english" coder="">Cellulose disodium phosphate</synonym>
    <synonym language="english" coder="">Cellulose sodium phosphate</synonym>
  </synonyms>
  <products/>
  <international-brands>
    <international-brand>
      <name>Calcibind</name>
      <company>Mission Pharma</company>
    </international-brand>
  </international-brands>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Biopolymers</category>
      <mesh-id>D001704</mesh-id>
    </category>
    <category>
      <category>Calcium Binder</category>
      <mesh-id/>
    </category>
    <category>
      <category>Calcium Chelating Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Cation Exchange Resins</category>
      <mesh-id>D002411</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Drugs for Treatment of Hypercalcemia</category>
      <mesh-id/>
    </category>
    <category>
      <category>Glucans</category>
      <mesh-id>D005936</mesh-id>
    </category>
    <category>
      <category>Macromolecular Substances</category>
      <mesh-id>D046911</mesh-id>
    </category>
    <category>
      <category>Polymers</category>
      <mesh-id>D011108</mesh-id>
    </category>
    <category>
      <category>Polysaccharides</category>
      <mesh-id>D011134</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes>
    <atc-code code="V03AG01">
      <level code="V03AG">Drugs for treatment of hypercalcemia</level>
      <level code="V03A">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V03">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V">VARIOUS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Sodium_cellulose_phosphate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1201457</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0004817</id>
      <name>Calcium ions</name>
      <organism>Humans</organism>
      <actions>
        <action>binder</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A31694</ref-id>
            <pubmed-id>3896714</pubmed-id>
            <citation>Lake KD, Brown DC: New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate. Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):530-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>